North America Cell Line Development Market share to amass significant gains by 2024

Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market. Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth. According to the Graphical Research new growth forecast report titled "North America Cell Line Development Market analysis based on Product, Source, Cell Line, Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024", estimated to exceed USD 2.7 billion by 2024.

Request for a sample of this report @ https://www.graphicalresearch.com/request/1067/sample

 

Presence of dominant industry players in U.S. focusing on developing advanced cell line development products coupled with favorable regulatory structure and innovation in development of biologics due to patent expiration will drive North America cell line development market. However, concerns pertaining to stem cell research will hinder industry growth over the forecast timeframe.

Reagent and media product segment accounted for largest market share in 2017 and is estimated to follow similar trend over the coming years due to its numerous applications in development of regenerative medicines, bio production, drug discovery, tissue engineering toxicity testing and research. Non-mammalian source segment will witness considerable growth during the forecast period owing to its noteworthy applications in insecticide screening and toxicology study.

Hybridomas cell line type segment is forecasted to witness robust growth during the forecast timeframe. Hybridoma technology is most widely used process for large scale production of monoclonal antibodies. The success of monoclonal antibodies in improving quality of life in patients suffering from cancer, autoimmune diseases and anti-inflammatory disorders have led to increased R&D for developing monoclonal antibodies for various critical health conditions will positively impact growth of cell line development market.

Request for customization this report @

https://www.graphicalresearch.com/request/1067/customize-this-report

 

Canada cell line development market will grow considerably during the forecast period owing to numerous efforts undertaken by Canadian government to advance stem cell research and development of stable cell lines for bioproduction in the country. Growing awareness about cell-based therapy, innovation in development of biologics and rising prevalence of cancer will stimulate growth of Canada cell line development market.

Key industry players operating in North America cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy. Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry.

 

Report Content

 

Chapter 3. North America Cell Line Development Market Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing vaccine production
3.3.1.2. Increasing cancer prevalence
3.3.1.3. Growth in biotechnology industry
3.3.1.4. Innovations in biologics due to patent expirations
3.3.1.5. Rising demand for monoclonal antibodies
3.3.1.6. Technological innovation in cell line development
3.3.2. Industry pitfalls & challenges
3.3.2.1. Issues related to stem cell research
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By source
3.4.3. By cell-line type
3.4.4. By application
3.5. Competitive landscape, 2017
3.5.1. Strategy dashboard
3.6. Porter's analysis
3.7. PESTEL analysis

Chapter 4. North America Cell Line Development Market, By Product

4.1. Key segment trends
4.2. Reagents and media
4.2.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3. Equipment
4.3.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3.2. Incubators
4.3.2.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3.3. Centrifuges
4.3.3.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3.4. Bioreactors
4.3.4.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3.5. Storage equipment
4.3.5.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.3.6. Microscopes
4.3.6.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
4.4. Accessories
4.4.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)

Browse key industry insights along with Full TOC @ https://www.graphicalresearch.com/table-of-content/1067/north-america-cell-line-development-market